Thanks to the support of our donor community, philanthropy is driving advancements in health care at Providence Saint Joseph Medical Center (PSJMC). From the implementation of a neonatal therapeutic hypothermia program and cutting-edge technology in the NICU to the enhancement of emergency cardiac care and the expansion of genetic medicine, generous donors are making a profound impact on patient care and outcomes. Discover how these donor-supported innovations are transforming lives and shaping the future of health care at Providence Saint Joseph Medical Center.

AngelEye Health camera and patient engagement platform
In 2016, thanks to the success of the Mother Baby campaign, PSJMC’s neonatal intensive care unit (NICU) became one of the first in the region to adopt a brand-new web camera system for parents to view a live stream of their babies from anywhere in the world. Since then, live-streaming video advancements for NICUs have greatly progressed.

Thanks to the generosity of the Hissrich family, PSJMC was able to upgrade the web camera system in the NICU to AngelEye Health. This brand-new state-of-the-art camera system not only allows parents to view their children but also offers options for further patient engagement. The system allows for breast milk management, online patient education and PatientConnect, a social media-like patient platform for NICU families and caregivers to interact with one another. This system allows parents to become an even more informed and active part of the care team, allowing them to view and access vital information and capture more precious moments.

Giraffe incubator beds
Over the last four years, also thanks to the support of the Hissrich family and the help of our grateful patient community, PSJMC has slowly started to transition NICU Giraffe incubator beds to the newest, most advanced technology. AngeleEye Health cameras integrate with the upgraded Giraffe beds to provide a state-of-the-art NICU for our patient families.

EEG monitor
The Providence Saint Joseph Medical Center neonatal therapeutic hypothermia program is a leading-edge service offered to patient families. The use of therapeutic hypothermia in newborns, also known as body cooling, slows down the progression of any adverse biochemical reactions during birth and preserves long-term neurologic outcomes. This process involves continuous EEG monitoring of the newborn’s neurologic status to record the brain’s electrical activity and function.

Thanks to the generous support of the Morad family, the EEG monitor, essential to the therapeutic hypothermia program, is available and provides lifesaving care by enabling us to receive newborns from other medical centers in the region.

ECG machines in the Jaromír Střížka Emergency Department
As a designated specialty center for treating acute heart attack patients, PSJMC’s Jaromír Střížka Emergency Department serves a high volume of patients in need of cardiac monitoring. As part of the $78 million Minutes Matter Emergency Services Campaign, the Henry L. Guenther Foundation proudly supported purchasing seven new electrocardiogram (ECG) systems. The updated ECG models offer a faster response time and more accurate results than the previous ECG fleet housed in the emergency department. This new fleet will standardize cardiac patient care services offering new technology that has many more capabilities, both clinically and for improved workflow.

Apostolos Psychogios, M.D.
Regional associate director and medical geneticist 
Thanks to the long-standing partnership with and philanthropic support of the John C. Hench Foundation, Apostolos Psychogios, M.D., has been brought on board as the associate medical geneticist for the Providence Center for Clinical Genetics and Genomics, which covers Providence’s presence across Southern California. As a medical geneticist, Dr. Psychogios is helping to predict, diagnose and treat diseases more precisely and personally than ever before. Dr. Psychogios is focused on expanding this clinical program, which has a profound impact on human health, by incorporating genetics into cardiovascular and neurological advances, providing patients with a full continuum of care.